Pacific Biosciences Of California (PACB) Return on Capital Employed Growth (1y) (2014 - 2026)
Pacific Biosciences Of California (PACB) Return on Capital Employed Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 216.00 |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | 6,914.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,914.00 |
| Mar 31, 2026 | 6,412.00 |
| Dec 31, 2025 | -4,004.00 |
| Sep 30, 2025 | -5,983.00 |
| Jun 30, 2025 | -5,992.00 |
| Mar 31, 2025 | -6,283.00 |
| Dec 31, 2024 | -1,743.00 |
| Sep 30, 2024 | -902.00 |
| Jun 30, 2024 | -789.00 |
| Mar 31, 2024 | 64.00 |
| Dec 31, 2023 | 72.00 |
| Sep 30, 2023 | -365.00 |
| Jun 30, 2023 | -678.00 |
| Mar 31, 2023 | -932.00 |
| Dec 31, 2022 | -295.00 |
| Jun 30, 2022 | -368.00 |
| Mar 31, 2022 | 201.00 |
| Dec 31, 2021 | 1,562.00 |
| Jun 30, 2021 | 9,964.00 |
| Mar 31, 2021 | 16,042.00 |